Lite Strategy Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.97

-0.11 (-9.99%)

Analyst Consensus

Strong Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 3 50%

Sell 3 50%

Price Target

Analyst Price Target +3,814.2% upside

Low Target $26.78

Average Target $38.05

High Target $46.02

Current Price $0.97

Current
$0.97

Target
$38.05

$26.78 $38.05 avg $46.02

Scenario Analysis

Bear Case

$26.78

2,654.9%

Low target

Base Case

$38.05

+3,814.2%

Avg target

Bull Case

$46.02

+4,634.1%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$2.26

-57.0% from high

52-Week Low

$0.69

+41.1% from low

Target vs 52W High

$38.05

+1,583.6% vs high

Next Earnings Report

Nov 12, 2026

until earnings

Earnings in 5 days. Analyst targets may shift significantly after the report.

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-10.6%
AMGN Amgen Inc	Hold	42	43%	$190.87	-58.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+116.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-19.2%
MRNA Moderna Inc	Hold	31	35%	$149.45	-38.1%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-91.5%
NTRA Natera Inc	Strong Buy	30	90%	$142.91	-60.7%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-35.8%